ATROSAB, a humanized antagonistic anti-tumor necrosis factor receptor one-specific antibody

Single chain TNF derivatives with individually mutated receptor binding sites reveal differential stoichiometry of ligand receptor complex formation for TNFR1 and TNFR2

(2010) Verena Boschert et al.   CELLULAR SIGNALLING

The treatment of established murine collagen-induced arthritis with a TNFR1-selective antagonistic mutant TNF

(2009) Hiroko Shibata et al.   BIOMATERIALS

Dual function of cysteine rich domain (CRD) 1 of TNF receptor type 1: Conformational stabilization of CRD2 and control of receptor responsiveness

(2009) Marcus Branschädel et al.   CELLULAR SIGNALLING

12th international TNF conference: The good, the bad and the scientists

(2009) David Wallach et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Antagonists of TNF action: clinical experience and new developments

(2009) Roland E Kontermann et al.   Expert Opinion on Drug Discovery

A Humanized Tumor Necrosis Factor Receptor 1 (TNFR1)-specific Antagonistic Antibody for Selective Inhibition of Tumor Necrosis Factor (TNF) Action

(2009) Roland E. Kontermann et al.   JOURNAL OF IMMUNOTHERAPY

Dominant‐Negative Tumor Necrosis Factor Protects fromMycobacterium bovisBacillus Calmette‐Guérin (BCG) and Endotoxin‐Induced Liver Injury without Compromising Host Immunity to BCG andMycobacterium tuberculosis

(2009) Maria L. Olleros et al.   JOURNAL OF INFECTIOUS DISEASES

The therapeutic effect of TNFR1-selective antagonistic mutant TNF-α in murine hepatitis models

(2008) Hiroko Shibata et al.   CYTOKINE

Murine endoglin-specific single-chain Fv fragments for the analysis of vascular targeting strategies in mice

(2008) Dafne Müller et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Tumour necrosis factor antagonists: structure, function, and tuberculosis risks

(2008) Robert S Wallis   LANCET INFECTIOUS DISEASES

Tumor necrosis factor antagonist mechanisms of action: A comprehensive review

(2007) Daniel Tracey et al.   PHARMACOLOGY & THERAPEUTICS